UPDATE 1-Sanofi completes Genzyme takeover

WASHINGTON, April 8 (Reuters) - Sanofi-Aventis said it has completed its takeover of U.S. biotechnology company Genzyme Corp , whose shares will cease trading on the Nasdaq as of the market close on Friday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.